Inclisiran Sodium-impurities | Pharmaffiliates

Inclisiran Sodium

Inclisiran Sodium, sold under the brand name Leqvio, is a medication for the treatment of people with atherosclerotic cardiovascular disease (ASCVD), ASCVD risk-equivalents, and heterozygous familial hypercholesterolemia (HeFH). Reference standards of Inclisiran Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Inclisiran Sodium - API Standards 
    [catalogue_number] => PA 09 1400000
    [category_ids] => ,76,78,70,82,
    [chemical_name] => 
    [weight] => NA
    [form] => NA
    [cas] => 1639324-62-1
    [pslug] => 1639324-62-1-inclisiran-sodium-api-pa091400000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)

Inclisiran Sodium - API Standards


  • Catalogue No.:PA 09 1400000

  • CAS :

    1639324-62-1

  • Molecular Formula : NA

  • Molecular Weight : NA